| Dr Wendy Moss Diffey, RPH, PHARMD | |
|
215 Us Highway 31 S, Athens, AL 35611-2892 | |
| (256) 233-0514 | |
| Not Available |
| Full Name | Dr Wendy Moss Diffey |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 215 Us Highway 31 S, Athens, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285238972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13735 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wendy Moss Diffey, RPH, PHARMD 113 Bellingham Dr, Madison, AL 35758-6829 Ph: (256) 783-4734 | Dr Wendy Moss Diffey, RPH, PHARMD 215 Us Highway 31 S, Athens, AL 35611-2892 Ph: (256) 233-0514 |
News Archive
Although botulinum toxin A injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for patients with chronic migraine headaches and chronic daily headaches, although botox injections were not associated with greater benefit than placebo for preventing episodic migraine or chronic tension-type headaches, according to an article in the April 25 issue of JAMA.
Residents at U.S. neurosurgery training programs strongly oppose new regulations that further limit their duty hours, according to a survey study in the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.
› Verified 7 days ago
Dr. Jeremy Glenn Moses, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 Us Highway 72 E, Athens, AL 35611 Phone: 256-233-3568 | |
Mark Kent Jackson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 605 Hwy 31 South, Suite D, Athens, AL 35611 Phone: 256-232-8274 | |
Deborah Suggs, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Us Highway 31 S Ste H, Athens, AL 35611 Phone: 256-232-8448 Fax: 256-232-1302 | |
Maria Strickland, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Us Highway 31 N, Athens, AL 35611 Phone: 256-230-2799 | |
Dr. Trevor Reynolds, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 Us Highway 72 E, Athens, AL 35611 Phone: 256-233-3568 | |
Dr. Julius Tate, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 Us Highway 31 S, Athens, AL 35611 Phone: 256-233-0514 |